Medroloan II SUIK (methylprednisolone acetate) NDC 76420-262

NDC codes

FDA NDC Directory

Product NDC (as listed)76420-262Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76420-0262Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76420-262-01	76420026201	2 VIAL, SINGLE-DOSE in 1 CARTON (76420-262-01) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jun 29, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Medroloan II SUIK
Generic name (nonproprietary): methylprednisolone acetate
Active ingredients: Methylprednisolone acetate — 40 mg/mL
Dosage form: Injection, Suspension
Route: Intra-articular, Intralesional, Intramuscular, Soft tissue
Labeler: Asclemed USA, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jun 29, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 76420-262_efecfdf4-cb6c-34bb-e053-2995a90a37a5SPL ID efecfdf4-cb6c-34bb-e053-2995a90a37a5SPL set ID 18dacdba-793c-490d-aa73-9e76bec41faeUNII 43502P7F0P
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J1040 — Injection, methylprednisolone acetate, 80 mg

Billing unit: 80 mg. Units on the claim = dose given ÷ 80 mg.

J1040 applies to methylprednisolone acetate. Methylprednisolone sodium succinate (for IV use) has different codes.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N476420026201 followed by a unit qualifier and the quantity

Package 76420-0262-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 9, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE A. For Intramuscular Administration When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension is indicated as follows: Allergic States : Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases : Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)